Fifth Third Bancorp Ironwood Pharmaceuticals Inc Transaction History
Fifth Third Bancorp
- $27.1 Billion
- Q4 2024
A detailed history of Fifth Third Bancorp transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 3,366 shares of IRWD stock, worth $5,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,366
Previous 1,442
133.43%
Holding current value
$5,419
Previous $5,000
180.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$36.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$31.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$26.4 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$18.9 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$15.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $247M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...